Study of ARO-HSD in Healthy Volunteers and Patients With Non-Alcoholic Steatohepatitis (NASH) or Suspected NASH
Clinical trial NCT04202354 · COMPLETED
Trial details
- NCT number
- NCT04202354
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-03
- Primary completion
- 2021-09-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.